Kewaunee Scientific Corp (KEQU)
NASDAQConsumer DiscretionaryFurnishings, Fixtures & AppliancesSnapshot 2026-09-04
$36.99+0.52%
Close 2026-09-04 · 1-day change
NASDAQConsumer DiscretionaryFurnishings, Fixtures & AppliancesSnapshot 2026-09-04
QuarterlyIQ Insights · KEQU
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -23.1% |
| Our one-year growth estimate | diamond | 8.3% |
Growth built into the price is above our model estimate.
The price assumes 31.4 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Worth watching into the next print: this name has been missing across recent quarters and is a smaller-cap name (higher miss base rate). A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 16 industry peers
KEQU — credit agreement
Dated 2025-12-04
Entry into a Material Definitive Agreement. On December 4, 2025, Kewaunee Scientific Corporation (the "Company") entered into a First Amendment to Loan Agreement (the "First Amendment") with PNC Bank, National Association ("PNC"). The First Amendment amends the Loan Agreement, dated as of November 1, 2024 (the "Loan Agreement"), between the Company and PNC to, among other things, (i) permit the Company to repay in full the outstanding principal balances of the subordinated seller notes issued…
Why it matters: Reducing debt would make Kewaunee's balance sheet stronger and give it more financial options.
Supportive ifLong-term debt decreases further from $40.851 million reported at the end of fiscal 2026.
Worry ifLong-term debt increases or remains unchanged from $40.851 million.
Why it matters: Keeping an eye on debt levels is important. It shows Kewaunee's financial health.
Worry ifLong-term debt drops from $40.9 million. This shows good debt management.
Less concerning ifLong-term debt is up or stays above $40.9 million. This shows financial strain.
Why it matters: If revenue grows, it may show a change in the weak consumer discretionary sector. This could boost investor confidence in Kewaunee.
Supportive ifKewaunee reports a year-over-year revenue increase for the next quarter.
Worry ifKewaunee keeps reporting lower revenue each year.
Why it matters: Backlog changes indicate future revenue potential. A growing backlog shows demand, while a shrinking one may signal issues.
Watch forLab Products Group backlog rises to $118.8 million. This shows strong demand.
Also watch forLab Products Group backlog drops below $100 million. This suggests weaker demand.
Why it matters: A drop over 21.3% shows big problems in the international market.
Worry ifInternational sales for Q3 drop more than 21.3% compared to the previous year.
Less concerning ifInternational sales for Q3 stay steady or grow from last year.
Why it matters: The earnings report will provide key insights into Kewaunee's performance and outlook. This could impact how investors view the stock.
Watch forThe earnings report shows better financial results. It also gives positive guidance.
Also watch forThe earnings report shows lower metrics and negative guidance.
Why it matters: A drop in EBITDA would show less profit due to operational problems.
Worry ifQ3 EBITDA falls below $6 million.
Less concerning ifQ3 EBITDA remains above $6 million.
Why it matters: If sales drop more, it shows problems with project delivery and market demand.
Worry ifLab Products Group sales fall more than 2% compared to the prior year's Q3.
Less concerning ifLab Products Group sales increase or decline less than 2% compared to the prior year's Q3.
Why it matters: A bigger drop would show worse demand and problems for Kewaunee.
Worry ifQ4 revenue drops more than 7.5% compared to the prior year's Q4.
Less concerning ifQ4 revenue declines less than 7.5% or increases year over year.
Why it matters: The earnings report will show if Kewaunee continues its revenue growth and profitability. Investors will look for trends in sales and EBITDA.
Watch forQ1 FY2027 revenue is over $70 million. This shows continued growth.
Also watch forRevenue for Q1 FY2027 falls below $60 million, suggesting a decline in performance.
Why it matters: Challenges could hurt profits and growth, especially in the Lab Products Group.
Worry ifManagement says they became more efficient and controlled costs better in Q1 FY2027.
Less concerning ifManagement points out ongoing challenges and cost pressures in Q1 FY2027.
Why it matters: Integrating Nu Aire is important. It will improve Kewaunee's products and revenue.
Supportive ifManagement says Nu Aire helped boost revenue in Q1 FY2027.
Worry ifManagement sees problems with Nu Aire integration in Q1 FY2027.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$109 on $10,000 · ±1.1% | How much price usually moves either way. |
| Bad day | $361 loss on $10,000 · 3.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,801 loss on $10,000 · 38.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.